FOLH1 and prostate cancer: Regarding focal radiotherapy treatment escalation in non-metastatic primary prostate cancer patients, an important issue is the potential correlation between quantitative PSMA ligand uptake measures and tumor aggressiveness, e.g. its correlation with the histopathological defined Gleason score.